2019年冠状病毒病(COVID-19)
环介导等温扩增
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
冠状病毒
大流行
病毒学
人口
RNA提取
核糖核酸
医学
计算生物学
生物
传染病(医学专业)
疾病
基因
DNA
病理
环境卫生
遗传学
生物化学
作者
Yoon Ok Jang,Hyo Joo Lee,Bonhan Koo,Hye-Hee Cha,Ji‐Soo Kwon,Ji Yeun Kim,Myoung Gyu Kim,Hyun Soo Kim,Sung‐Han Kim,Yong Shin
出处
期刊:Biosensors
[MDPI AG]
日期:2021-10-06
卷期号:11 (10): 373-373
被引量:8
摘要
The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus (SARS-CoV)-2, is rapidly spreading and severely straining the capacities of public health communities and systems around the world. Therefore, accurate, rapid, and robust diagnostic tests for COVID-19 are crucial to prevent further spread of the infection, alleviate the burden on healthcare and diagnostic facilities, and ensure timely therapeutic intervention. To date, several detection methods based on nucleic acid amplification have been developed for the rapid and accurate detection of SARS-CoV-2. Despite the myriad of advancements in the detection methods for SARS-CoV-2, rapid sample preparation methods for RNA extraction from viruses have rarely been explored. Here, we report a rapid COVID-19 molecular diagnostic system that combines a self-powered sample preparation assay and loop-mediated isothermal amplification (LAMP) based naked-eye detection method for the rapid and sensitive detection of SARS-CoV-2. The self-powered sample preparation assay with a hydrophilic polyvinylidene fluoride filter and dimethyl pimelimidate can be operated by hand, without the use of any sophisticated instrumentation, similar to the reverse transcription (RT)-LAMP-based lateral flow assay for the naked-eye detection of SARS-CoV-2. The COVID-19 molecular diagnostic system enriches the virus population, extracts and amplifies the target RNA, and detects SARS-CoV-2 within 60 min. We validated the accuracy of the system by using 23 clinical nasopharyngeal specimens. We envision that this proposed system will enable simple, facile, efficient, and inexpensive diagnosis of COVID-19 at home and the clinic as a pre-screening platform to reduce the burden on the medical staff in this pandemic era.
科研通智能强力驱动
Strongly Powered by AbleSci AI